abstract |
Ear, ear and nose compositions containing a new class of antibiotics (e. G. Moxifloxacin) are disclosed. The composition preferably also contains one or more anti-inflammatory agents. The composition can be used to treat eye, ear and nose symptoms by topically applying the composition to the infected tissue. |